Neuronetics lands FDA clearance for TMS therapy accessory
The devices use a coil to deliver magnetic pulses that stimulate nerve cells in the brain in regions responsible for mood regulation. Image credit: Shutterstock/E-ART. Neuronetics has received US Food and Drug Administration (FDA) clearance for its NeuroSite Coil placement accessory, a tool that helps users with accurate coil placement. US-based Neuronetics was the first […]
Signal: Illumina to divest Grail, ending years-long legal battle
Illumina announced on Sunday that it would divest Grail. Photo: Getty Images. Illumina, the embattled diagnostics company at the heart of a years-long antitrust battle over its acquisition of cancer test manufacturer Grail, has finally put an end to the saga by announcing that it will divest the company in 2024. The announcement follows the […]
Thubrikar’s TAVI trial gets greenlight to expand in Poland
Data from the first five patients participating in the TAVI-1 trial, found there was clinical improvement within one year. Credit: Shutterstock / HealthyCapture Studio A clinical trial examining the use of Thubrikar Aortic Valve’s transcatheter aortic valve implantation (TAVI)system has been given the greenlight to expand its remit by the Polish authorities. Thubrikar Aortic Valve […]
Zeiss acquires Dutch Ophthalmic Research Center in $1bn deal
Carl Zeiss Meditec’s acquisition of the Dutch Ophthalmic Research Center was valued at approximately €985m ($1.07bn). Image Credit: Mats Wiklund / Shutterstock. Carl Zeiss Meditec has entered an agreement to acquire Dutch Ophthalmic Research Center to expand its ophthalmic device portfolio. As per the agreement, Zeiss will acquire 100% of the shares in DORC from […]
Atomic AI unveil large language model for RNA-drug discovery
The market for AI platforms for the healthcare industry is forecast to reach $4.3bn by 2024. Credit: NicoElNino via ShutterStock. US-based biotech company Atomic AI has introduced ATOM-1, a propriety platform component, representing a large language model (LLM) that leverages chemical mapping data to predict the structure and function of ribonucleic acid (RNA). The goal […]
Seegene, Microbix partner for Quality Assessment Products in US
Seegene will distribute and recommend Microbix’s QAPs for monitoring the workflow accuracy of Seegene Novaplex and Allplex assays used across the US. Credit: Tatiana from Pixabay. Molecular assay provider Seegene USA has collaborated with Microbix Biosystems for the latter’s QAPS. Under the deal, Seegene will supply and recommend the QAPs for monitoring the workflow accuracy […]
NuEyes receives clearance for augmented reality loupes
NuLoupes’s high-resolution variable digital magnification provides surgeons and dentists with a broader field of view. Credit: anatoliy_gleb / Shutterstock.com. NuEyes has received approval from the US Food and Drug Administration (FDA) for its new augmented reality loupes, NuLoupes. NuLoupes is claimed to be the first pair of smart glasses to receive FDA clearance, featuring live […]
Femasys starts birth control solution trial at Stanford Medicine
The trial is intended to assess the efficacy and safety of a non-surgical solution for permanent birth control. Credit: fizkes / Shutterstock.com. Femasys has initiated the enrolment of subjects at Stanford Medicine in Palo Alto, California, US, for FemBloc, a non-implant, non-surgical in-office solution for permanent birth control. The FemBloc Intratubal Occlusion for Transcervical Permanent […]
SeekIn, Oncolnv partner to expand access to cancer detection tests
As of December 2023, Oncolnv will distribute SeekIn’s cancer detection tests across 12 countries. Credit: OsloMetX from Pixabay. SeekIn has entered a strategic collaboration with Oncolnv to globally expand the accessibility of its multiple cancer detection tests. The agreement was made official at the Inspire2Live Annual Congress in Amsterdam, the Netherlands, held last month. As […]
Atropos Health and Seqster partner for registry-based research
The lack of recruitment of racial minorities, women, and other groups in trials means there is an inherent bias in trial results. Image credit: Shutterstock/Hilch. Healthcare data companies Atropos Health and Seqster are targeting underrepresented populations in clinical trials after the two companies formed a strategic partnership to establish turnkey patient registries. Atropos, a provider […]